Functional CT Quantification of Tumor Perfusion after Transhepatic Arterial Embolization in a Rat Model
Authors:
- Zuxing KanZKZuxing Kan
- Satoshi KobayashiSKSatoshi Kobayashi
- Sith PhongkitkarunSPSith Phongkitkarun
- Chusilp CharnsangavejCCChusilp Charnsangavej
- 1 October 2005
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 237 (1) , 144-150
Abstract
To quantify tumor perfusion after transcatheter arterial embolization (TAE) with functional computed tomography (CT) and to validate the reproducibility of quantification measurements. This study was conducted in accordance with an institutional animal care and use committee-approved protocol. Sixteen rats with liver tumors underwent TAE with 1 mg (group 1) or 3 mg (group 2) of polyvinyl alcohol particles. In each group, four rats underwent functional CT immediately after TAE (day 0) and four others underwent functional CT 2 days after TAE (day 2). Another four rats served as control rats. Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area product were measured by using a functional CT software program. For evaluation of reproducibility, six additional rats with mammary tumors underwent functional CT twice, with examinations 2 hours apart. The mixed-effect model was used to assess the TAE treatment effect, and the Pearson correlation test was used to determine measurement reproducibility. With the exception of BF in group 1 on day 2 (P = .41), BF and BV values in both groups on both days were significantly lower than BF and BV values in the control rats (with P values ranging from .018 to <.001). BF was significantly lower in group 2 than in group 1 on days 0 and 2 (P = .043 and P = .02, respectively). BV was significantly lower on day 2 than on day 0 in group 2 (P = .016). MTT was generally inversely related to BF. MTTs in group 2 on days 0 and 2 were significantly longer than those in the control rats (P < .001 and P = .03, respectively), and MTT was shorter on day 2 than on day 0 in group 2 (P = .02). Permeability-surface area product changes were similar to BF changes. There were no significant differences (P values ranged from .2 to .5) between perfusion parameters in the reproducibility study. The results of this study validate the use of functional CT in the quantification of tumor perfusion after TAE and the reproducibility of such quantification measurements.Keywords
This publication has 28 references indexed in Scilit:
- Functional CT: physiological modelsTrends in Biotechnology, 2002
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled TrialsRadiology, 2002
- Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s PerspectiveAnnals of Surgery, 2002
- Natural history of hepatocellular carcinoma including fibrolamellar and hepato‐cholangiocarcinoma variantsJournal of Gastroenterology and Hepatology, 2002
- Efficacy and Safety of Preoperative Lobar or Segmental Ablation via Transarterial Administration of Ethiodol and Ethanol Mixture for Treatment of Hepatocellular Carcinoma: Clinical StudyWorld Journal of Surgery, 2000
- Embolization and chemoembolization therapy for neuroendocrine tumorsCurrent Opinion in Oncology, 1999
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Carcinoid Tumors: Imaging Procedures and Interventional RadiologyWorld Journal of Surgery, 1996
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Current status of transcatheter management of neoplasmsCardioVascular and Interventional Radiology, 1980